Matches in Nanopublications for { ?s ?p "DDI between Duloxetine and Ciprofloxacin - Ciprofloxacin, a strong CYP1A2 inhibitor, may decrease the metabolism of duloxetine. Monitor for changes in the therapeutic and adverse effects of duloxetine if ciprofloxacin is initiated or discontinued. [drugbank_resource:DB00476_DB00537]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00476_DB00537 label "DDI between Duloxetine and Ciprofloxacin - Ciprofloxacin, a strong CYP1A2 inhibitor, may decrease the metabolism of duloxetine. Monitor for changes in the therapeutic and adverse effects of duloxetine if ciprofloxacin is initiated or discontinued. [drugbank_resource:DB00476_DB00537]" assertion.